Search the Newsroom
Filter By
News Type
Showing 1 - 7 of 7 results
STRIVE-ing for Comprehensive Care for DSD in One Program
Experts in the STRIVE Program work collaboratively to delivery comprehensive care to children with differences in sexual development/intersex and other conditions.
FDA Approves First Potentially Curative Gene Therapy for Beta Thalassemia
A leading study site for nearly a decade, CHOP will be part of a network of treatment centers in the country offering the therapy to patients who require regular blood transfusions.
New Data Show Benefits of CRISPR-edited Gene Therapy for Blood Disorders in a Larger Patient Group with Longer-Term Follow-Up
A group of researchers that includes CHOP presented new data on CRISPR-edited gene therapy for blood disorders at an international meeting.
Coping with a Dual Diagnosis
Parents are usually blindsided when they find out that their child has congenital hyperinsulinism (HI), a rare genetic disorder that depresses blood sugar to dangerously low levels.
Psychologist Joins Adrenal and Puberty Center Team
Last fall, Leela Morrow, PsyD, joined the Adrenal and Puberty Center at Children’s Hospital of Philadelphia, adding another service to the comprehensive program.
The Rare Intersection of HI and Turner Syndrome
Sometimes rare and super rare genetic conditions occur within the same child. That’s the case for Turner syndrome, which has an incidence rate of about 1 in 2,500 female births, and congenital hyperinsulinism, which happens about once in 50,000 births.
Psychologist Joins HI Team
Last fall, Leela Morrow, PsyD, joined the team at the Congenital Hyperinsulinism Center at Children’s Hospital of Philadelphia, adding another service to the comprehensive program.